Endocarditis after Transcatheter Aortic Valve Replacement

Lorenzo Braghieri, Simrat Kaur, Christopher K. Black, Paul C. Cremer, Shinya Unai, Samir R. Kapadia, Amgad Mentias*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Transcatheter aortic valve replacement (TAVR) use is gaining momentum as the mainstay for the treatment of aortic stenosis compared to surgical aortic valve replacement (SAVR). Unfortunately, TAVR-related infective endocarditis (TAVR-IE) is expected to be detected more and more as a result of the ever-expanding indications in younger patients. Given the overall poor prognosis of TAVR-IE, it is imperative that clinicians familiarize themselves with common presentations, major risk factors, diagnostic pitfalls, therapeutic approaches, and the prevention of TAVR-IE. Herein, we review all of the above in detail with the most updated available literature.

Original languageEnglish (US)
Article number7042
JournalJournal of Clinical Medicine
Issue number22
StatePublished - Nov 2023


  • SAVR
  • TAVR
  • aortic valve replacement
  • infective endocarditis
  • transcatheter aortic valve replacement

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Endocarditis after Transcatheter Aortic Valve Replacement'. Together they form a unique fingerprint.

Cite this